Another nine hypermethylated CpG sites can reduce the expression of CDK2AP1, which encodes cyclin-dependent kinase 2 (CDK2), which is important in the reducing of cell proliferation, contributes to cell cycle termination, and is a known tumor suppressor [63]. This evidence concerns the gene CDK2AP1 and neoplasm.